Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00094510 · ClinicalTrials.gov registry record

Effect of Gabapentin on GABA Concentration and Emotional Processing

A clinical trial, sponsored by National Institute of Mental Health (NIMH).

Completed
Registry status
30
Enrollment target

NCT00094510 is a clinical trial that has completed, run by National Institute of Mental Health (NIMH). The registered enrollment target is 30 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00094510 has completed, sponsored by National Institute of Mental Health (NIMH).

COMPLETED
Registry status
30 participants
Enrollment target

Study Summary

This study will use magnetic resonance spectroscopy (MRS) and the drug gabapentin to examine the role of the brain chemical gamma-amino-butyric acid (GABA) in regulating emotions in healthy people. Gabapentin, which is used to treat epilepsy, increases GABA concentrations in the brain. MRS, similar to magnetic resonance imaging (MRI), is a diagnostic test that uses a magnetic field and radio waves to produce images of the brain. Non-smoking, healthy normal volunteers between 18 and 60 years of age may be eligible for this study. Candidates are screened with a medical history and physical examination, psychiatric evaluation, blood and urine tests, and an electrocardiogram (EKG). At three separate clinic visits, participants are given either gabapentin or a placebo (an inactive look-alike capsule). They take placebo at one visit, 600 mg of gabapentin at another visit, and 1200 mg of gabapentin at another visit. One hour after taking the capsules, the amount of GABA in the brain is measured by MRS. For this procedure, the subject lies on a table that moves into the MRI scanner (a narrow cylinder), wearing earplugs to muffle loud knocking and thumping sounds that occur during the scanning process. The procedure lasts about 45 to 60 minutes, during which the patient is asked to lie still for up to a few minutes at a time.

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2004-10-14
Est. Completion 2010-09-03

What the Registry Record Tells You About NCT00094510

The ClinicalTrials.gov registry entry for NCT00094510 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Mental Health (NIMH), which has 343 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00094510 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00094510 about?

NCT00094510 is a clinical study titled "Effect of Gabapentin on GABA Concentration and Emotional Processing". This study will use magnetic resonance spectroscopy (MRS) and the drug gabapentin to examine the role of the brain chemical gamma-amino-butyric acid (GABA) in regulating emotions in healthy people. Gabapentin, which is used to treat epilepsy, increases GABA concentrations in the brain. MRS, similar ...

What is the current status of trial NCT00094510?

This trial is currently completed. The enrollment target is 30 participants. The study started on 2004-10-14. Estimated completion is 2010-09-03.

Who is sponsoring clinical trial NCT00094510?

This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.